Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyHimisha Beltran, Martin Gleave, Michael J. Morris et al.|Clinical Cancer Research|2017Cited by 75